MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin.

Yu, Minmin; Xu, Baozhen; Yang, Hui; Xue, Songlin; Zhang, Rong; Zhang, Hongmei; Ying, Xiaoyan; Dai, Zhiqin

Yu, Minmin; Xu, Baozhen; Yang, Hui; Xue, Songlin; Zhang, Rong; Zhang, Hongmei; Ying, Xiaoyan; Dai, Zhiqin.

Afiliação

Yu M; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, People's Republic of China.
Xu B; Department of Obstetrics and Gynecology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, People's Republic of China.
Yang H; Department of Obstetrics and Gynecology, Nanjing Lishui People's Hospital, Nanjing 211200, People's Republic of China.
Xue S; Department of Obstetrics and Gynecology, Huaian Maternal and Child Health Care Hospital, Huaian 223002, People's Republic of China.
Zhang R; Department of Obstetrics and Gynecology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, People's Republic of China.
Zhang H; Department of Obstetrics and Gynecology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, People's Republic of China.
Ying X; Department of Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, People's Republic of China.
Dai Z; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, People's Republic of China.

Cancer Manag Res ; 11: 6511-6519, 2019.

Article em En | MEDLINE | ID: mdl-31372052

Palavras-chave

apoptosis; cervical cancer; cisplatin resistant; miR-218; survivin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google